Search results
Abortion pill’s hazy legal future
Politico· 3 hours agoBut don’t expect legal fights over the drug to fizzle just yet. The ruling didn’t address the merits of the challengers’ case against FDA policy changes that expanded access ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 14 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 1 day agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
FDA must fix “inadequate” inspection and recall policies, report says
Just Food via Yahoo Finance· 1 day agoReleased today by the Department of Health and Human Services Office of Inspector General (OIG), the...
SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: Experts
ABC7 News· 8 hours agoThe court unanimously struck down a lawsuit seeking to restrict nationwide access to mifepristone,...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 day agoHigh hopes that psychedelic medicines were finally on the pathway to regulation were dashed last...
CT-based Charles Boggini Company recalls sodas, lemonade
Stamford Advocate· 5 hours agoThe FDA has initiated a recall for products made by a Connecticut soda company which the agency said...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
FDA took months to react to complaint about Abbott infant formula factory, audit finds
The News-Times· 21 hours agoThe Department of Labor received the email and three days later forwarded it to an FDA address...
FDA took months to react to complaint about Abbott infant formula factory, audit finds
ABC 26 New Orleans· 21 hours agoThe U.S. Food and Drug Administration took more than 15 months to act on a whistleblower complaint...
